These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33541763)

  • 1. Hemodynamic Changes Associated With Transcervical Laryngeal Injection of Botulinum Toxin.
    Hernandez BO; Nagatsuka M; Wright SC; Marcellino AJ; Lovin BD; Walker FO; Madden LL
    J Voice; 2023 May; 37(3):452-455. PubMed ID: 33541763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesia in Transcutaneous Laryngeal Botulinum Toxin Injections: A Randomized Crossover Trial.
    Heyes R; Adler CH; Yee C; Lott DG; Karle WE
    Laryngoscope; 2024 May; 134(5):2277-2281. PubMed ID: 38157199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved vocal quality and decreased vocal effort after botulinum toxin treatment for laryngeal dystonia.
    Leung JS; Rosenbaum A; Holmberg J; Villarroel P; Napolitano C; Badía PI; Lagos-Villaseca A
    Auris Nasus Larynx; 2024 Feb; 51(1):106-112. PubMed ID: 37365040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laryngeal dystonia: a series with botulinum toxin therapy.
    Blitzer A; Brin MF
    Ann Otol Rhinol Laryngol; 1991 Feb; 100(2):85-9. PubMed ID: 1992905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients].
    Teive HA; Scola RH; Werneck LC; Quadros Ad ; Gasparetto EL; Sá DS; Brandi IV; Macedo Filho ED
    Arq Neuropsiquiatr; 2001 Mar; 59(1):97-100. PubMed ID: 11299440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
    Loven JO; Brøndbo K; Ganes T
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Office-based endoscopic botulinum toxin injection in laryngeal movement disorders.
    Kaderbay A; Righini CA; Castellanos PF; Atallah I
    Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Jun; 135(3):205-207. PubMed ID: 29661610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laryngeal Botulinum Toxin Injection: Can It Be a Cause of Obstructive Sleep Apnea as an Adverse Effect?
    Oktay Arslan B; Demirhan E; Uçar Hoşgör ZZ
    J Voice; 2022 Jan; 36(1):119-122. PubMed ID: 32482493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia.
    Yeung W; Richards AL; Novakovic D
    Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice Patterns and Barriers in Botulinum Toxin Injection for the Treatment of Voice Disorders.
    McGarey PO; Simpson CB; Daniero JJ
    J Voice; 2022 Jan; 36(1):113-118. PubMed ID: 32467003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications for botulinum toxin in laryngectomy].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E; Cohen M
    Rev Laryngol Otol Rhinol (Bord); 1993; 114(4):281-7. PubMed ID: 8029549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia.
    Holzer SE; Ludlow CL
    Laryngoscope; 1996 Jan; 106(1 Pt 1):86-92. PubMed ID: 8544635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: comparing different botulinum toxin preparations.
    Truong DD; Bhidayasiri R
    Eur J Neurol; 2006 Feb; 13 Suppl 1():36-41. PubMed ID: 16417596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Experience Contributing to Outcomes of Laryngeal Botulinum Toxin Injection.
    Rutt A; Kennelly KD; Martinez-Paredes JF
    J Voice; 2022 Mar; 36(2):272-276. PubMed ID: 32553551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vocal aging and adductor spasmodic dysphonia: response to botulinum toxin injection.
    Cannito MP; Kahane JC; Chorna L
    Clin Interv Aging; 2008; 3(1):131-51. PubMed ID: 18488884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic and therapeutic difficulties in laryngeal dystonia].
    Niebudek-Bogusz E; Modzelewska-Radwan B; Pietruszewska W; Zielińska M; Gryczyński M
    Otolaryngol Pol; 2003; 57(5):739-45. PubMed ID: 14994622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laryngeal image analysis following botulinum toxin injections in spasmodic dysphonia.
    Wong DL; Irish JC; Adams SG; Durkin LC; Hunt EJ
    J Otolaryngol; 1995 Feb; 24(1):64-8. PubMed ID: 7769649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review.
    Watts C; Nye C; Whurr R
    Clin Rehabil; 2006 Feb; 20(2):112-22. PubMed ID: 16541931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin injection in laryngeal dyspnea.
    Woisard V; Liu X; Bes MC; Simonetta-Moreau M
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):909-917. PubMed ID: 27600559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.